According to the current analysis of Reports and Data, the Global Coronary Stents Market was valued at USD 8.95 Billion in 2019 and is expected to reach USD 16.58 Billion by the year 2027 at a CAGR of 7.9%. Stents are small expandable tubes that are used to treat narrowed or weakened arteries. A coronary stent is a small mesh tube that holds open passages in the body, such as weak or narrow arteries. It is a small tube-shaped device placed in the coronary arteries, which supply blood to the heart, to keep the arteries open in the treatment of coronary heart diseases.
The coronary stents are used in almost all the percutaneous coronary intervention (PCI) procedures. Stents reduce chest pains and have been proven to have improved chances of survival and decrease adverse events in acute myocardial infarction. Coronary Stents market is continuously growing. With the rising advancements and launch of new products, there is massive scope for the product.
Request free sample Copy of this research report to Understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/1736
Further key findings from the report suggest
- Minimal invasiveness has been attracting the attention of many in recent times. Since Coronary Angioplasty is one of the types of minimally intrusive treatments, there has been a spur of growth in the demand for this procedure. Increasing cases of coronary artery diseases have triggered research and development initiatives to develop several innovative solutions for treatment purposes, which lays a foundation for future growth.
- Hospitals dominate the market with a market share of 63%. This is due to the extensive facilities offered in hospitals.
- The coronary stents are of two types in terms of delivery. These include balloon expandable stents and self-expandable stents.
- The existence of alternatives for coronary angioplasty has also become a restraining factor for the coronary stents market. These alternatives include procedures such as Atherectomy, Laser angioplasty, coronary artery bypass, etc.
- Recent developments have boosted the growth of the market considerably. For instance, the recent launch of Dual Therapy Stents (DTS) is a one of its kind type of stent. The DTS is a combination of Drug Eluding Stents and Bio-engineered Stent. It has a coating on the inside as well as outside, making the chances of blood clots, inflammations, and tissue injuries less likely. DTS is seen to grow at a rate of 8.8%.
- Among the types of stents, Drug-Eluting Stents, being the most time tested type of stents, dominate the market. They are considered to be the safest and the most time tested among all the other types of stents. They are expected to grow at a rate of 7.7%.
- North America dominates the market with the highest market share. The changing dietary habits and cases of obesity have led to an increase in the cases of CAD, i.e., Coronary Artery Disease. The market is expected to grow at a CAGR of 7.7%.
- Europe follows North America closely and holds the highest market share, amounting to 30.4%. This can be attributed to the rising technological advancements in the region. The region is expected to register a CAGR of 7.6%.
- Asia Pacific is seen to be the fastest-growing region with a CAGR of 8.7%. This can be attributed to the increasing geriatric population in the region and the rising cases of Coronary Artery Disease. Several governments in this region have taken initiatives to make medical facilities and surgical procedures affordable. The Asia Pacific holds a market share of around 26.6%.
- The key players of the market include Boston Scientific Corporation, Medtronic Plc, Abbott Laboratories, B. Braun Melsungen AG, Vascular Concepts, Stentys SA, Biosensors International Group Ltd., and Orbus Neich.
Buy Your Exclusive Copy Now (Customized report delivered as per your specific requirement) @ https://www.reportsanddata.com/checkout-form/1736
For the purpose of this report, Reports and Data has segmented the Coronary Stents market on the basis of type, material, end-use, and region:
By Type (Revenue, USD Million; 2017–2027)
- Dual Therapy Stents
- Drug Eluting Stents
- Bio-engineered Stents
- Bare Metal Stents
- Bioresorbable Vascular Scaffold (BVS)
By End-Use (Revenue, USD Million; 2017–2027)
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
By Material (Revenue, USD Million; 2017–2027)
- Metal
- Polymer
- Copolymer
Regional Outlook (Revenue in USD Million; 2017–2027)
- North America
- S.
- Canada
- Europe
- Germany
- France
- K.
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Middle East & Africa
- Latin America
- Brazil
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/coronary-stents-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
